Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM in Sjögren's Syndrome
NCT04111341Phase 2Completed
- Sponsor
- Chung Shan Medical University
- Start
- May 2016
- Primary completion
- Oct 2017
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Gan-Lu-Yin and jia wei xiao yao san in Sjögren's syndrome (2 arms), sponsored by Chung Shan Medical University. Primary endpoint: European Sjögren's Syndrome Patient Reported Index at 12 weeks. Started May 2016; status: completed.
02
Drugs
Gan-Lu-Yinjia wei xiao yao san
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT04111341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111341.